Cybin Therapeutics, kampani yabizinesi yazachipatala yomwe ili ndi cholinga chopeza ndikukhazikitsa njira zochiritsira zothandizidwa ndi psilocybin, yapereka chilolezo cha PEX010 (25 mg) kuchokera ku Filament kuti igwiritsidwe ntchito poyesa. Mlanduwu ukuyembekezeka kuyamba mu Q3'22 ndipo uphatikiza anthu omwe ali ndi vuto lalikulu la kuvutika maganizo omwe akulandira chithandizo chosankha cha serotonin reuptake inhibitor (SSRI), chomwe chimagwiritsidwa ntchito pochiza kuvutika maganizo, komanso omwe ali ndi SSRI-naive.

"Chivomerezo cha Health Canada ndi umboni wotsimikizira kuti mayeserowa ndi olondola komanso kuti Filament ali ndi mphamvu zopanga ndi kupereka chilolezo kwa anthu omwe akufunafuna mankhwala opangira mankhwala," anatero Filament Chief Executive Officer, Benjamin Lightburn. "Zotsatira za chithandizo cha psilocybin mwa odwala omwe amamwa mankhwala oletsa kupsinjika maganizo a SSRI ndi kafukufuku wofunikira kwambiri ndipo ndife okondwa kutenga nawo mbali pa kafukufuku wofunikirawu."

"Anthu ambiri a ku Canada omwe ali ndi vuto la kuvutika maganizo amalandila chithandizo cha SSRI, ndipo mpaka pano, izi zapangitsa kuti asalowe m'mayesero achipatala a psychedelic assisted psychotherapy (PAP)," anatero Josh Taylor, Woyambitsa Cybin Therapeutics. "Ngati zingathe kuwonetsedwa kuti PAP ikhoza kuperekedwa mosamala komanso moyenera kwa odwala pa SSRIs, ambiri adzapindula. Tikuwona kuti uwu ndi mwayi wabwino kwambiri wowonetsa Health Canada kuti Cybin Therapeutics imatha kusintha zotsatira za odwala ndi gulu lathu ndikupanga ma protocol. ”

Filament yaperekanso chilolezo cha PEX010 (25 mg) ku CT kwa mayesero owonjezera a 2, omwe akuyembekezeka kuyamba gawo lachinayi la 2022. Mayesero onsewa adzatsogoleredwa ndi Dr. Reg Peters ndi Dave Phillips.